Sign up Australia
Proactive Investors - Run By Investors For Investors

Zelda Therapeutics brings medical cannabis trials to Proactive's CEO Sessions

Find out more from Dr. Stewart Washer at Proactive's CEO Sessions.
Zelda Therapeutics at the Proactive's CEO Sessions
Dr. Stewart Washer, managing director, will present at Proactive's CEO Sessions

Zelda Therapeutics Ltd (ASX:ZLD) is developing a range of cannabinoid-based formulations to treat medical conditions, and recently sponsored an observation autism trial in Chile.

The trial demonstrated successful results for treating the core symptoms of autism with medicinal cannabis extracts that Zelda is planning on taking into clinical trials.

Results showed that in a cohort of 21 patients, cannabis extracts were significantly more effective than conventional medicines used, including atypical antipsychotics, and these extracts were well tolerated by the patients overall.

Find out more from Dr. Stewart Washer at Proactive's CEO Sessions.

Click below to register by email

- Melbourne: Tuesday 14th November.
- Sydney: Wednesday 15th November.
- Email Pauline here.
- Call office on (02) 9280 0700.

Presenter list

- Zelda Therapeutics (ASX:ZLD): Dr. Stewart Washer
- Thred Ltd (ASX:THD): Geoff Marshall
- De Grey Mining (ASX:DEG): Simon Lill
- Peninsula Energy (ASX:PEN): David Coyle
- Aspire Mining (ASX:AKM): David Paull


Join our Crypto, Blockchain and Cannabis Telegram group here
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

medical cannabis
October 01 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy
cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use